We design artificial intelligence systems and generate multi-modal omics data to build OrganoMaps. OrganoMaps link disease biology and treatment interventions at the organ level to develop novel medicines for patients in need.
External link for AI VIVO
Cowley Road
Cambridge, England CB4 0, GB
AI for cell biology at Sanger Institute, University of Cambridge, scientific co-founder at AI VIVO
It was great to work with Nature Method on this piece about foundations models for cell biology, while we are not there yet, the future is bright. Effective training of these models guided by tasks and evaluations that are non trivial with careful benchmarking against existing models can facilitate and more importantly expedites discovery in cell biology! Read open access: shorturl.at/JekyX
Excited to share this role at AI VIVO . If you're passionate about operations & AI in drug discovery, we would love to hear from you. Apply now and join our amazing team!
Excited to share this role at AI VIVO . If you're passionate about computational biology and GenAI in drug discovery, we would love to hear from you. Apply now and join our amazing team!
Excited to share this role at AI VIVO . If you're passionate about GenAI in drug discovery, we would love to hear from you. Apply now and join our amazing team!
We are very excited to share the news of having Mo Lotfollahi as the scientific co-founder! at AI VIVO Mo brings a wealth of experience in AI for biology advancements with a proven track record and will play a pivotal role in enhancing our organ level drug discovery platform and pipeline. Together, we are poised to make significant strides in revolutionizing the pharmaceutical landscape! stay tuned!